THIS WEEK IN OBESITY: Gibson and Dr. Perreault discuss the possibility or lack thereof that we can prevent and/or reverse diabetes and obesity. March 6, 2025
THIS WEEK IN OBESITY: Dr. Gibson and Dr. Perreault discuss the concept that there may or may not be an obesity set point throughout various stages of life. March 4, 2025
Dr. Gibson and Dr. Perreault discuss her PATHWEIGH study for pragmatic weight management in primary care. February 28, 2025
THIS WEEK IN NEPHROLOGY: Dr. Parikh and I discuss the definition and implementation of the Four Pillars of Care in patients with renal insufficiency. February 26, 2025
THIS WEEK IN NEPHROLOGY: Dr. Parikh and I discuss exciting new developments Xenotransplantation for patients with renal insufficiency. February 26, 2025
Dr. McGuire, Dr. Jastreboff, and Dr. C. Michael Gibson discuss best practices for titration of GLP-1 medications for optimal weight loss. February 17, 2025 Disclosures: TBD
Dr. McGuire, Dr. Jastreboff, and Dr. C. Michael Gibson explore the question of what is the right weight reduction for each patient taking GLP-1 medications? February 12, 2025 Disclosures: TBD
Dr. McGuire, Dr. Jastreboff, and Dr. C. Michael Gibson discuss the SUMMIT trial and how GLP-1 agonists may be a new pillar in the treatment for HFpEF and obesity. January 30, 2025 Disclosures: TBD
Dr. McGuire, Dr. Jastreboff, and Dr. C. Michael Gibson discuss new oral semaglutide and the SOUL trial which lowered death, MI and stroke rates by 14% in patients with diabetes. December 18, 2024 Disclosures: TBD
Dr. McGuire, Dr. Jastreboff and Dr. C Michael Gibson discuss the SURMOUNT 1 Trial of Tirzepatide and how we may be able to diminish the progression from pre-diabetes to diabetes. December 9, 2024 Disclosures: TBD
